{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:06:19Z","timestamp":1793495179034,"version":"4.5.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T00:00:00Z","timestamp":1356048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Mol Cell Biol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1038\/nrm3495","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T11:33:00Z","timestamp":1356003180000},"page":"38-48","source":"Crossref","is-referenced-by-count":495,"title":["Molecular basis of physiological heart growth: fundamental concepts and new players"],"prefix":"10.1038","volume":"14","author":[{"given":"Marjorie","family":"Maillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jop H.","family":"van Berlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery D.","family":"Molkentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,21]]},"reference":[{"key":"BFnrm3495_CR1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"128","author":"BC Bernardo","year":"2010","unstructured":"Bernardo, B. C., Weeks, K. L., Pretorius, L. & McMullen, J. R. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol. Ther. 128, 191\u2013227 (2010).","journal-title":"Pharmacol. Ther."},{"key":"BFnrm3495_CR2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke, J. & Molkentin, J. D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nature Rev. Mol. Cell Biol. 7, 589\u2013600 (2006).","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnrm3495_CR3","unstructured":"Van Berlo, J. H., Maillet, M. & Molkentin, J. D. Signaling effectors underlying pathologic growth and remodeling of the heart. J. Clin. Invest. (in the press)."},{"key":"BFnrm3495_CR4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","volume":"324","author":"O Bergmann","year":"2009","unstructured":"Bergmann, O. et al. Evidence for cardiomyocyte renewal in humans. Science 324, 98\u2013102 (2009).","journal-title":"Science"},{"key":"BFnrm3495_CR5","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1161\/CIRCULATIONAHA.112.118380","volume":"126","author":"J Kajstura","year":"2012","unstructured":"Kajstura, J. et al. Cardiomyogenesis in the aging and failing human heart. Circulation 126, 1869\u20131881 (2012).","journal-title":"Circulation"},{"key":"BFnrm3495_CR6","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/HYPERTENSIONAHA.106.079426","volume":"49","author":"GW Dorn","year":"2007","unstructured":"Dorn, G. W. The fuzzy logic of physiological cardiac hypertrophy. Hypertension 49, 962\u2013970 (2007).","journal-title":"Hypertension"},{"key":"BFnrm3495_CR7","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1440-1681.2008.05036.x","volume":"35","author":"ER Porrello","year":"2008","unstructured":"Porrello, E. R., Widdop, R. E. & Delbridge, L. M. Early origins of cardiac hypertrophy: does cardiomyocyte attrition programme for pathological 'catch-up' growth of the heart? Clin. Exp. Pharmacol. Physiol. 35, 1358\u20131364 (2008).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"BFnrm3495_CR8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/01.RES.32.6.685","volume":"32","author":"SF Hopkins Jr","year":"1973","unstructured":"Hopkins, S. F. Jr, McCutcheon, E. P. & Wekstein, D. R. Postnatal changes in rat ventricular function. Circ. Res. 32, 685\u2013691 (1973).","journal-title":"Circ. Res."},{"key":"BFnrm3495_CR9","first-page":"571","volume":"50","author":"FJ Clubb Jr","year":"1984","unstructured":"Clubb, F. J. Jr & Bishop, S. P. Formation of binucleated myocardial cells in the neonatal rat. An index for growth hypertrophy. Lab. Invest. 50, 571\u2013577 (1984).","journal-title":"Lab. Invest."},{"key":"BFnrm3495_CR10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.tcm.2006.07.001","volume":"16","author":"M Eghbali","year":"2006","unstructured":"Eghbali, M., Wang, Y., Toro, L. & Stefani, E. Heart hypertrophy during pregnancy: a better functioning heart? Trends Cardiovasc. Med. 16, 285\u2013291 (2006).","journal-title":"Trends Cardiovasc. Med."},{"key":"BFnrm3495_CR11","first-page":"151","volume":"82","author":"T Winsor","year":"1955","unstructured":"Winsor, T. & Beckner, G. Hypertrophy of the heart; electrocardiographic distinction between physiologic and pathologic enlargement. Calif. Med. 82, 151\u2013158 (1955).","journal-title":"Calif. Med."},{"key":"BFnrm3495_CR12","first-page":"15","volume":"2","author":"S Henschen","year":"1899","unstructured":"Henschen, S. Skilanglauf and skiwettlauf: ein medizinische sportstudie. Mitt. Med. Klin. Uppsala 2, 15\u201318 (1899).","journal-title":"Mitt. Med. Klin. Uppsala"},{"key":"BFnrm3495_CR13","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/01.CIR.61.4.832","volume":"61","author":"T Nishimura","year":"1980","unstructured":"Nishimura, T., Yamada, Y. & Kawai, C. Echocardiographic evaluation of long-term effects of exercise on left ventricular hypertrophy and function in professional bicyclists. Circulation 61, 832\u2013840 (1980).","journal-title":"Circulation"},{"key":"BFnrm3495_CR14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0002-8703(83)90527-6","volume":"105","author":"Y Sugishita","year":"1983","unstructured":"Sugishita, Y., Koseki, S., Matsuda, M., Yamaguchi, T. & Ito, I. Myocardial mechanics of athletic hearts in comparison with diseased hearts. Am. Heart J. 105, 273\u2013280 (1983).","journal-title":"Am. Heart J."},{"issue":"Suppl. 7","key":"BFnrm3495_CR15","first-page":"135","volume":"74","author":"HH Dickhuth","year":"1985","unstructured":"Dickhuth, H. H., Reindell, H., Lehmann, M. & Keul, J. [Capacity for regression of the athletic heart]. Z. Kardiol. 74 (Suppl. 7), 135\u2013143 (1985).","journal-title":"Z. Kardiol."},{"key":"BFnrm3495_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000057675","volume":"97","author":"CM Schannwell","year":"2002","unstructured":"Schannwell, C. M. et al. Left ventricular hypertrophy and diastolic dysfunction in healthy pregnant women. Cardiology 97, 73\u201378 (2002).","journal-title":"Cardiology"},{"key":"BFnrm3495_CR17","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1542\/peds.105.5.e63","volume":"105","author":"KF Janz","year":"2000","unstructured":"Janz, K. F., Dawson, J. D. & Mahoney, L. T. Predicting heart growth during puberty: The Muscatine Study. Pediatrics 105, e63 (2000).","journal-title":"Pediatrics"},{"key":"BFnrm3495_CR18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/bdrb.10034","volume":"68","author":"KW Hew","year":"2003","unstructured":"Hew, K. W. & Keller, K. A. Postnatal anatomical and functional development of the heart: a species comparison. Birth Defects Res. B. Dev. Reprod. Toxicol. 68, 309\u2013320 (2003).","journal-title":"Birth Defects Res. B. Dev. Reprod. Toxicol."},{"key":"BFnrm3495_CR19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/01.CIR.101.3.336","volume":"101","author":"BM Pluim","year":"2000","unstructured":"Pluim, B. M., Zwinderman, A. H., van der Laarse, A. & van der Wall, E. E. The athlete's heart. A meta-analysis of cardiac structure and function. Circulation 101, 336\u2013344 (2000).","journal-title":"Circulation"},{"key":"BFnrm3495_CR20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0002-9149(78)90984-0","volume":"42","author":"AA Ehsani","year":"1978","unstructured":"Ehsani, A. A., Hagberg, J. M. & Hickson, R. C. Rapid changes in left ventricular dimensions and mass in response to physical conditioning and deconditioning. Am. J. Cardiol. 42, 52\u201356 (1978).","journal-title":"Am. J. Cardiol."},{"key":"BFnrm3495_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/hrt.69.2.125","volume":"69","author":"BJ Maron","year":"1993","unstructured":"Maron, B. J., Pelliccia, A., Spataro, A. & Granata, M. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br. Heart J. 69, 125\u2013128 (1993).","journal-title":"Br. Heart J."},{"key":"BFnrm3495_CR22","first-page":"1","volume":"24","author":"G Sarquella-Brugada","year":"2012","unstructured":"Sarquella-Brugada, G. et al. Genetics of sudden cardiac death in children and young athletes. Cardiol. Young 24, 1\u201315 (2012).","journal-title":"Cardiol. Young"},{"key":"BFnrm3495_CR23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11040","volume":"485","author":"IS Patten","year":"2012","unstructured":"Patten, I. S. et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485, 333\u2013338 (2012).","journal-title":"Nature"},{"key":"BFnrm3495_CR24","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/BF01906411","volume":"71","author":"HW Heiss","year":"1976","unstructured":"Heiss, H. W. et al. Studies on the regulation of myocardial blood flow in man. I.: Training effects on blood flow and metabolism of the healthy heart at rest and during standardized heavy exercise. Bas. Res. Cardiol. 71, 658\u2013675 (1976).","journal-title":"Bas. Res. Cardiol."},{"key":"BFnrm3495_CR25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/s-2007-1024775","volume":"11","author":"A Pelliccia","year":"1990","unstructured":"Pelliccia, A. et al. Coronary arteries in physiological hypertrophy: echocardiographic evidence of increased proximal size in elite athletes. Int. J. Sports Med. 11, 120\u2013126 (1990).","journal-title":"Int. J. Sports Med."},{"key":"BFnrm3495_CR26","doi-asserted-by":"crossref","first-page":"H10","DOI":"10.1152\/ajpheart.00574.2011","volume":"302","author":"MH Laughlin","year":"2012","unstructured":"Laughlin, M. H., Bowles, D. K. & Duncker, D. J. The coronary circulation in exercise training. Am. J. Physiol. Heart Circ. Physiol. 302, H10\u2013H23 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrm3495_CR27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/FJC.0b013e3181e74a14","volume":"56","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk, G. D. & Jaswal, J. S. Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J. Cardiovasc. Pharmacol. 56, 130\u2013140 (2010).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"BFnrm3495_CR28","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1172\/JCI113822","volume":"82","author":"EW Gertz","year":"1988","unstructured":"Gertz, E. W., Wisneski, J. A., Stanley, W. C. & Neese, R. A. Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. J. Clin. Invest. 82, 2017\u20132025 (1988).","journal-title":"J. Clin. Invest."},{"key":"BFnrm3495_CR29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cvr\/cvr015","volume":"90","author":"ED Abel","year":"2011","unstructured":"Abel, E. D. & Doenst, T. Mitochondrial adaptations to physiological versus pathological cardiac hypertrophy. Cardiovasc. Res. 90, 234\u2013242 (2011). In-depth review of the mitochondrial adaptations to physiological or pathological cardiac hypertrophic signals. Describes how the distinct cardiac metabolic profiles associated with physiological and pathological hypertrophy are initiated by specific signalling pathways: PI3K, AMPK and PGC1\u03b1.","journal-title":"Cardiovasc. Res."},{"key":"BFnrm3495_CR30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.0000109415.17511.18","volume":"94","author":"BJ Wilkins","year":"2004","unstructured":"Wilkins, B. J. et al. Calcineurin\/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res. 94, 110\u2013118 (2004).","journal-title":"Circ. Res."},{"key":"BFnrm3495_CR31","first-page":"H151","volume":"270","author":"ML Burgess","year":"1996","unstructured":"Burgess, M. L. et al. Exercise- and hypertension-induced collagen changes are related to left ventricular function in rat hearts. Am. J. Physiol. 270, H151\u2013H159 (1996).","journal-title":"Am. J. Physiol."},{"key":"BFnrm3495_CR32","doi-asserted-by":"crossref","first-page":"H2994","DOI":"10.1152\/ajpheart.2000.279.6.H2994","volume":"279","author":"H Jin","year":"2000","unstructured":"Jin, H. et al. Effects of exercise training on cardiac function, gene expression, and apoptosis in rats. Am. J. Physiol. Heart Circ. Physiol. 279, H2994\u2013H3002 (2000).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrm3495_CR33","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/hh2301.100982","volume":"89","author":"GG Neri Serneri","year":"2001","unstructured":"Neri Serneri, G. G. et al. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ. Res. 89, 977\u2013982 (2001).","journal-title":"Circ. Res."},{"key":"BFnrm3495_CR34","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/01.RES.86.2.e29","volume":"86","author":"D Bellomo","year":"2000","unstructured":"Bellomo, D. et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ. Res. 86, e29\u2013e35 (2000).","journal-title":"Circ. Res."},{"key":"BFnrm3495_CR35","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/CIRCRESAHA.108.178459","volume":"103","author":"T Karpanen","year":"2008","unstructured":"Karpanen, T. et al. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy. Circ. Res. 103, 1018\u20131026 (2008).","journal-title":"Circ. Res."},{"key":"BFnrm3495_CR36","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.110.957332","volume":"122","author":"M Bry","year":"2010","unstructured":"Bry, M. et al. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation 122, 1725\u20131733 (2010).","journal-title":"Circulation"},{"key":"BFnrm3495_CR37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/s-0028-1093482","volume":"10","author":"P Stubbe","year":"1978","unstructured":"Stubbe, P., Gatz, J., Heidemann, P., Muhlen, A. & Hesch, R. Thyroxine-binding globulin, triiodothyronine, thyroxine and thyrotropin in newborn infants and children. Horm. Metab. Res. 10, 58\u201361 (1978).","journal-title":"Horm. Metab. Res."},{"key":"BFnrm3495_CR38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3940(00)00768-0","volume":"280","author":"N Hadj-Sahraoui","year":"2000","unstructured":"Hadj-Sahraoui, N., Seugnet, I., Ghorbel, M. T. & Demeneix, B. Hypothyroidism prolongs mitotic activity in the post-natal mouse brain. Neurosci. Lett. 280, 79\u201382 (2000).","journal-title":"Neurosci. Lett."},{"key":"BFnrm3495_CR39","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/01.CIR.87.5.1451","volume":"87","author":"E Morkin","year":"1993","unstructured":"Morkin, E. Regulation of myosin heavy chain genes in the heart. Circulation 87, 1451\u20131460 (1993).","journal-title":"Circulation"},{"key":"BFnrm3495_CR40","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.yjmcc.2010.12.012","volume":"51","author":"R Arsanjani","year":"2011","unstructured":"Arsanjani, R., McCarren, M., Bahl, J. J. & Goldman, S. Translational potential of thyroid hormone and its analogs. J. Mol. Cell. Cardiol. 51, 506\u2013511 (2011).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrm3495_CR41","doi-asserted-by":"crossref","first-page":"20666","DOI":"10.1074\/jbc.M512671200","volume":"281","author":"A Kenessey","year":"2006","unstructured":"Kenessey, A. & Ojamaa, K. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J. Biol. Chem. 281, 20666\u201320672 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3495_CR42","doi-asserted-by":"crossref","first-page":"H381","DOI":"10.1152\/ajpheart.00576.2005","volume":"290","author":"A Kenessey","year":"2006","unstructured":"Kenessey, A., Sullivan, E. A. & Ojamaa, K. Nuclear localization of protein kinase C-\u03b1 induces thyroid hormone receptor-\u03b11 expression in the cardiomyocyte. Am. J. Physiol. Heart Circ. Physiol. 290, H381\u2013H389 (2006).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrm3495_CR43","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/en.2009-1241","volume":"151","author":"M Belakavadi","year":"2010","unstructured":"Belakavadi, M., Saunders, J., Weisleder, N., Raghava, P. S. & Fondell, J. D. Repression of cardiac phospholamban gene expression is mediated by thyroid hormone receptor-\u03b11 and involves targeted covalent histone modifications. Endocrinology 151, 2946\u20132956 (2010).","journal-title":"Endocrinology"},{"key":"BFnrm3495_CR44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0008-6363(97)00051-5","volume":"34","author":"RW Brownsey","year":"1997","unstructured":"Brownsey, R. W., Boone, A. N. & Allard, M. F. Actions of insulin on the mammalian heart: metabolism, pathology and biochemical mechanisms. Cardiovasc. Res. 34, 3\u201324 (1997).","journal-title":"Cardiovasc. Res."},{"key":"BFnrm3495_CR45","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1101\/gad.1492806","volume":"20","author":"I Shiojima","year":"2006","unstructured":"Shiojima, I. & Walsh, K. Regulation of cardiac growth and coronary angiogenesis by the Akt\/PKB signaling pathway. Genes Dev. 20, 3347\u20133365 (2006). Comprehensive review on the role of PI3K\u2013AKT signalling pathways in regulating physiological cardiac hypertrophy, cardiac contractile function and coronary angiogenesis.","journal-title":"Genes Dev."},{"key":"BFnrm3495_CR46","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/372186a0","volume":"372","author":"E Araki","year":"1994","unstructured":"Araki, E. et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372, 186\u2013190 (1994).","journal-title":"Nature"},{"key":"BFnrm3495_CR47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/35030105","volume":"407","author":"DJ Burks","year":"2000","unstructured":"Burks, D. J. et al. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407, 377\u2013382 (2000).","journal-title":"Nature"},{"key":"BFnrm3495_CR48","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1172\/JCI0213946","volume":"109","author":"DD Belke","year":"2002","unstructured":"Belke, D. D. et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J. Clin. Invest. 109, 629\u2013639 (2002). Shows that insulin signalling controls postnatal cardiac growth. Cardiomyocyte-specific IR knockout was shown to result in cardiomyocytes with a reduced volume, and postnatal contractile and metabolic switches were altered.","journal-title":"J. Clin. Invest."},{"key":"BFnrm3495_CR49","doi-asserted-by":"crossref","first-page":"H1261","DOI":"10.1152\/ajpheart.00108.2003","volume":"285","author":"P Hu","year":"2003","unstructured":"Hu, P. et al. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am. J. Physiol. Heart Circ. Physiol. 285, H1261\u2013H1269 (2003).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrm3495_CR50","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.yjmcc.2009.02.014","volume":"46","author":"S Sena","year":"2009","unstructured":"Sena, S. et al. Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction. J. Mol. Cell. Cardiol. 46, 910\u2013918 (2009).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrm3495_CR51","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.108.792101","volume":"119","author":"S Boudina","year":"2009","unstructured":"Boudina, S. et al. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation 119, 1272\u20131283 (2009).","journal-title":"Circulation"},{"key":"BFnrm3495_CR52","first-page":"955","volume":"42","author":"A Efstratiadis","year":"1998","unstructured":"Efstratiadis, A. Genetics of mouse growth. Int. J. Dev. Biol. 42, 955\u2013976 (1998).","journal-title":"Int. J. Dev. Biol."},{"key":"BFnrm3495_CR53","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1152\/jappl.1976.41.4.523","volume":"41","author":"J Sutton","year":"1976","unstructured":"Sutton, J. & Lazarus, L. A. Growth hormone in exercise: comparison of physiological and pharmacological stimuli. J. Appl. Physiol. 41, 523\u2013527 (1976).","journal-title":"J. Appl. Physiol."},{"key":"BFnrm3495_CR54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(05)80085-6","volume":"75","author":"J Baker","year":"1993","unstructured":"Baker, J., Liu, J. P., Robertson, E. J. & Efstratiadis, A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75, 73\u201382 (1993).","journal-title":"Cell"},{"key":"BFnrm3495_CR55","first-page":"59","volume":"75","author":"JP Liu","year":"1993","unstructured":"Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J. & Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75, 59\u201372 (1993). References 54 and 55 show that IGF1 signalling is essential for postnatal growth.","journal-title":"Cell"},{"key":"BFnrm3495_CR56","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.1073\/pnas.93.16.8630","volume":"93","author":"K Reiss","year":"1996","unstructured":"Reiss, K. et al. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc. Natl Acad. Sci. USA 93, 8630\u20138635 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3495_CR57","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1096\/fasebj.13.14.1923","volume":"13","author":"MC Delaughter","year":"1999","unstructured":"Delaughter, M. C., Taffet, G. E., Fiorotto, M. L., Entman, M. L. & Schwartz, R. J. Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice. FASEB J. 13, 1923\u20131929 (1999).","journal-title":"FASEB J."},{"key":"BFnrm3495_CR58","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1074\/jbc.M310405200","volume":"279","author":"JR McMullen","year":"2004","unstructured":"McMullen, J. R. et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110\u03b1) pathway. J. Biol. Chem. 279, 4782\u20134793 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3495_CR59","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1210\/me.2008-0265","volume":"22","author":"J Kim","year":"2008","unstructured":"Kim, J. et al. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Mol. Endocrinol. 22, 2531\u20132543 (2008). In this study, IGF1R targeted deletion in adult cardiomyocytes did not result in any baseline hypertrophic phenotype in young mice. IGF1R-targeted hearts were resistant to exercise induced hypertrophy.","journal-title":"Mol. Endocrinol."},{"key":"BFnrm3495_CR60","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1152\/ajpendo.00538.2011","volume":"303","author":"S Moellendorf","year":"2012","unstructured":"Moellendorf, S. et al. IGF-IR signaling attenuates the age-related decline of diastolic cardiac function. Am. J. Physiol. Endocrinol. Metab. 303, e213\u2013e222 (2012).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrm3495_CR61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00424-010-0847-8","volume":"460","author":"A Patel","year":"2010","unstructured":"Patel, A. et al. Canonical TRP channels and mechanotransduction: from physiology to disease states. Pflugers Arch. 460, 571\u2013581 (2010).","journal-title":"Pflugers Arch."},{"key":"BFnrm3495_CR62","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/23060","volume":"400","author":"A Musar\u00f2","year":"1999","unstructured":"Musar\u00f2, A., McCullagh, K. J., Naya, F. J., Olson, E. N. & Rosenthal, N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400, 581\u2013585 (1999).","journal-title":"Nature"},{"key":"BFnrm3495_CR63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ncb1218","volume":"7","author":"R Maroto","year":"2005","unstructured":"Maroto, R. et al. TRPC1 forms the stretch-activated cation channel in vertebrate cells. Nature Cell Biol. 7, 179\u2013185 (2005).","journal-title":"Nature Cell Biol."},{"key":"BFnrm3495_CR64","doi-asserted-by":"crossref","first-page":"16586","DOI":"10.1073\/pnas.0606894103","volume":"103","author":"MA Spassova","year":"2006","unstructured":"Spassova, M. A., Hewavitharana, T., Xu, W., Soboloff, J. & Gill, D. L. A common mechanism underlies stretch activation and receptor activation of TRPC6 channels. Proc. Natl Acad. Sci. USA 103, 16586\u201316591 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3495_CR65","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/CIRCRESAHA.109.206581","volume":"105","author":"M Seth","year":"2009","unstructured":"Seth, M. et al. TRPC1 channels are critical for hypertrophic signaling in the heart. Circ. Res. 105, 1023\u20131030 (2009).","journal-title":"Circ. Res."},{"key":"BFnrm3495_CR66","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1073\/pnas.1001825107","volume":"107","author":"X Wu","year":"2010","unstructured":"Wu, X., Eder, P., Chang, B. & Molkentin, J. D. TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc. Natl Acad. Sci. USA 107, 7000\u20137005 (2010). This study, along with reference 65, showed that TRPC channels are necessary mediators of cardiac hypertrophy.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3495_CR67","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/hh0402.105790","volume":"90","author":"SY Shai","year":"2002","unstructured":"Shai, S. Y. et al. Cardiac myocyte-specific excision of the \u03b21 integrin gene results in myocardial fibrosis and cardiac failure. Circ. Res. 90, 458\u2013464 (2002).","journal-title":"Circ. Res."},{"key":"BFnrm3495_CR68","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1096\/fj.08-127480","volume":"23","author":"RK Johnston","year":"2009","unstructured":"Johnston, R. K. et al. \u03b23 integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy. FASEB J. 23, 2759\u20132771 (2009).","journal-title":"FASEB J."},{"key":"BFnrm3495_CR69","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijcard.2008.06.049","volume":"131","author":"L Cox","year":"2008","unstructured":"Cox, L., Umans, L., Cornelis, F., Huylebroeck, D. & Zwijsen, A. A broken heart: a stretch too far: an overview of mouse models with mutations in stretch-sensor components. Int. J. Cardiol. 131, 33\u201344 (2008).","journal-title":"Int. J. Cardiol."},{"key":"BFnrm3495_CR70","first-page":"637","volume":"77","author":"WA Linke","year":"2008","unstructured":"Linke, W. A. Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc. Res. 77, 637\u2013648 (2008).","journal-title":"Cardiovasc. Res."},{"key":"BFnrm3495_CR71","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","volume":"366","author":"DS Herman","year":"2012","unstructured":"Herman, D. S. et al. Truncations of titin causing dilated cardiomyopathy. N. Engl. J. Med. 366, 619\u2013628 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrm3495_CR72","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/emboj\/19.11.2537","volume":"19","author":"T Shioi","year":"2000","unstructured":"Shioi, T. et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19, 2537\u20132548 (2000).","journal-title":"EMBO J."},{"key":"BFnrm3495_CR73","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1073\/pnas.1934654100","volume":"100","author":"JR McMullen","year":"2003","unstructured":"McMullen, J. R. et al. Phosphoinositide 3-kinase(p110\u03b1) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc. Natl Acad. Sci. USA 100, 12355\u201312360 (2003). This study, along with reference 72, showed that PI3K\u03b1 regulates the physiological growth of the heart in gain and loss of function studies. PI3K\u03b1 activity controls exercise-induced physiological cardiac hypertrophy but not pathological hypertrophy.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3495_CR74","doi-asserted-by":"crossref","first-page":"9491","DOI":"10.1128\/MCB.25.21.9491-9502.2005","volume":"25","author":"J Luo","year":"2005","unstructured":"Luo, J. et al. Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol. Cell. Biol. 25, 9491\u20139502 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrm3495_CR75","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1161\/CIRCULATIONAHA.109.873380","volume":"120","author":"Z Lu","year":"2009","unstructured":"Lu, Z. et al. Loss of cardiac phosphoinositide 3-kinase p110\u03b1 results in contractile dysfunction. Circulation 120, 318\u2013325 (2009).","journal-title":"Circulation"},{"key":"BFnrm3495_CR76","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0092-8674(02)00969-8","volume":"110","author":"MA Crackower","year":"2002","unstructured":"Crackower, M. A. et al. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110, 737\u2013749 (2002). This study showed that PTEN deletion in cardiomyocytes promotes heart growth at the organ and cellular level. Overexpression of dominant negative p110\u03b1 downstream of PTEN normalizes the phenotype.","journal-title":"Cell"},{"key":"BFnrm3495_CR77","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/sj.emboj.7600218","volume":"23","author":"EJ McManus","year":"2004","unstructured":"McManus, E. J. et al. The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation. EMBO J. 23, 2071\u20132082 (2004).","journal-title":"EMBO J."},{"key":"BFnrm3495_CR78","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1093\/emboj\/cdg469","volume":"22","author":"A Mora","year":"2003","unstructured":"Mora, A. et al. Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia. EMBO J. 22, 4666\u20134676 (2003).","journal-title":"EMBO J."},{"key":"BFnrm3495_CR79","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.yjmcc.2004.05.015","volume":"37","author":"GY Oudit","year":"2004","unstructured":"Oudit, G. Y. et al. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J. Mol. Cell. Cardiol. 37, 449\u2013471 (2004).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrm3495_CR80","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1126\/science.292.5522.1728","volume":"292","author":"H Cho","year":"2001","unstructured":"Cho, H. et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB\u03b2). Science 292, 1728\u20131731 (2001).","journal-title":"Science"},{"key":"BFnrm3495_CR81","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1101\/gad.913901","volume":"15","author":"WS Chen","year":"2001","unstructured":"Chen, W. S. et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15, 2203\u20132208 (2001).","journal-title":"Genes Dev."},{"key":"BFnrm3495_CR82","doi-asserted-by":"crossref","first-page":"38349","DOI":"10.1074\/jbc.C100462200","volume":"276","author":"H Cho","year":"2001","unstructured":"Cho, H., Thorvaldsen, J. L., Chu, Q., Feng, F. & Birnbaum, M. J. Akt1\/PKB\u03b1 is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276, 38349\u201338352 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3495_CR83","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1161\/CIRCULATIONAHA.105.595231","volume":"113","author":"B DeBosch","year":"2006","unstructured":"DeBosch, B. et al. Akt1 is required for physiological cardiac growth. Circulation 113, 2097\u20132104 (2006).","journal-title":"Circulation"},{"key":"BFnrm3495_CR84","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/MCB.22.8.2799-2809.2002","volume":"22","author":"T Shioi","year":"2002","unstructured":"Shioi, T. et al. Akt\/protein kinase B promotes organ growth in transgenic mice. Mol. Cell. Biol. 22, 2799\u20132809 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrm3495_CR85","doi-asserted-by":"crossref","first-page":"22896","DOI":"10.1074\/jbc.M200347200","volume":"277","author":"T Matsui","year":"2002","unstructured":"Matsui, T. et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J. Biol. Chem. 277, 22896\u201322901 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3495_CR86","doi-asserted-by":"crossref","first-page":"12333","DOI":"10.1073\/pnas.172376399","volume":"99","author":"G Condorelli","year":"2002","unstructured":"Condorelli, G. et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc. Natl Acad. Sci. USA 99, 12333\u201312338 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3495_CR87","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1172\/JCI24682","volume":"115","author":"I Shiojima","year":"2005","unstructured":"Shiojima, I. et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 115, 2108\u20132118 (2005). Showed that conditional expression of AKT1 in the heart for 2 weeks induces a reversible physiological hypertrophy while sustained AKT1 expression for 6 weeks causes heart failure.","journal-title":"J. Clin. Invest."},{"key":"BFnrm3495_CR88","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.0000124394.01180.BE","volume":"94","author":"I Shiraishi","year":"2004","unstructured":"Shiraishi, I. et al. Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ. Res. 94, 884\u2013891 (2004).","journal-title":"Circ. Res."},{"key":"BFnrm3495_CR89","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/01.RES.0000196568.11624.ae","volume":"97","author":"M Rota","year":"2005","unstructured":"Rota, M. et al. Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circ. Res. 97, 1332\u20131341 (2005).","journal-title":"Circ. Res."},{"key":"BFnrm3495_CR90","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1083\/jcb.151.1.117","volume":"151","author":"S Haq","year":"2000","unstructured":"Haq, S. et al. Glycogen synthase kinase-3\u03b2 is a negative regulator of cardiomyocyte hypertrophy. J. Cell. Biol. 151, 117\u2013130 (2000).","journal-title":"J. Cell. Biol."},{"key":"BFnrm3495_CR91","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1073\/pnas.231619298","volume":"99","author":"CL Antos","year":"2002","unstructured":"Antos, C. L. et al. Activated glycogen synthase-3\u03b2 suppresses cardiac hypertrophy in vivo. Proc. Natl Acad. Sci. USA 99, 907\u2013912 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3495_CR92","doi-asserted-by":"crossref","first-page":"21383","DOI":"10.1074\/jbc.M401413200","volume":"279","author":"A Michael","year":"2004","unstructured":"Michael, A. et al. Glycogen synthase kinase-3\u03b2 regulates growth, calcium homeostasis, and diastolic function in the heart. J. Biol. Chem. 279, 21383\u201321393 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3495_CR93","doi-asserted-by":"crossref","first-page":"20814","DOI":"10.1074\/jbc.M500528200","volume":"280","author":"C Skurk","year":"2005","unstructured":"Skurk, C. et al. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J. Biol. Chem. 280, 20814\u201320823 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3495_CR94","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/hmg\/ddq570","volume":"20","author":"AJ Malhowski","year":"2011","unstructured":"Malhowski, A. J. et al. Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin. Hum. Mol. Genet. 20, 1290\u20131305 (2011). Showed that  Tsc1  deletion results in lethal developmental and postnatal cardiac hypertrophy that is reversed by rapamycin treatment.","journal-title":"Hum. Mol. Genet."},{"key":"BFnrm3495_CR95","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.yjmcc.2008.07.016","volume":"45","author":"Y Wang","year":"2008","unstructured":"Wang, Y. et al. Rheb activates protein synthesis and growth in adult rat ventricular cardiomyocytes. J. Mol. Cell. Cardiol. 45, 812\u2013820 (2008).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrm3495_CR96","doi-asserted-by":"crossref","first-page":"13842","DOI":"10.1074\/jbc.M801510200","volume":"283","author":"WH Shen","year":"2008","unstructured":"Shen, W. H. et al. Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mTOR-mediated signaling and cardiac function. J. Biol. Chem. 283, 13842\u201313849 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3495_CR97","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI43008","volume":"120","author":"D Zhang","year":"2010","unstructured":"Zhang, D. et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J. Clin. Invest. 120, 2805\u20132816 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrm3495_CR98","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.110.977066","volume":"123","author":"P Shende","year":"2011","unstructured":"Shende, P. et al. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation 123, 1073\u20131082 (2011). This study, along with reference 97, shows that cardiac-specific mTOR or RAPTOR ablation results in heart failure without an initial phase of hypertrophy.","journal-title":"Circulation"},{"key":"BFnrm3495_CR99","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1128\/MCB.24.14.6231-6240.2004","volume":"24","author":"JR McMullen","year":"2004","unstructured":"McMullen, J. R. et al. Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy. Mol. Cell. Biol. 24, 6231\u20136240 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrm3495_CR100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cyto.2010.12.019","volume":"54","author":"J Tsukada","year":"2011","unstructured":"Tsukada, J., Yoshida, Y., Kominato, Y. & Auron, P. E. The CCAAT\/enhancer (C\/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation. Cytokine 54, 6\u201319 (2011).","journal-title":"Cytokine"},{"key":"BFnrm3495_CR101","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.cell.2010.11.036","volume":"143","author":"P Bostrom","year":"2010","unstructured":"Bostrom, P. et al. C\/EBP\u03b2 controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 143, 1072\u20131083 (2010). Shows that C\/EBP\u03b2 is specifically downregulated by exercise training. C\/EBP\u03b2 downregulation increases cardiomyocyte proliferation and leads to the transcription of genes specific to exercise.","journal-title":"Cell"},{"key":"BFnrm3495_CR102","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","volume":"19","author":"OF Bueno","year":"2000","unstructured":"Bueno, O. F. et al. The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19, 6341\u20136350 (2000). Demonstrates that activation of MEK1\u2013ERK1\/2 signalling in the mouse heart induces a non-pathological form of compensated cardiac hypertrophy.","journal-title":"EMBO J."},{"key":"BFnrm3495_CR103","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.CIR.0000127126.73759.23","volume":"109","author":"DJ Lips","year":"2004","unstructured":"Lips, D. J. et al. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 109, 1938\u20131941 (2004).","journal-title":"Circulation"},{"key":"BFnrm3495_CR104","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.1073\/pnas.0610906104","volume":"104","author":"NH Purcell","year":"2007","unstructured":"Purcell, N. H. et al. Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc. Natl Acad. Sci. USA 104, 14074\u201314079 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3495_CR105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.110.231514","volume":"108","author":"I Kehat","year":"2011","unstructured":"Kehat, I. et al. Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth. Circ. Res. 108, 176\u2013183 (2011).","journal-title":"Circ. Res."},{"key":"BFnrm3495_CR106","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2009.05088.x","volume":"1188","author":"I Kehat","year":"2010","unstructured":"Kehat, I. & Molkentin, J. D. Extracellular signal-regulated kinase 1\/2 (ERK1\/2) signaling in cardiac hypertrophy. Ann. NY Acad. Sci. 1188, 96\u2013102 (2010).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrm3495_CR107","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11897-012-0102-z","volume":"9","author":"S Horman","year":"2012","unstructured":"Horman, S., Beauloye, C., Vanoverschelde, J. L. & Bertrand, L. AMP-activated protein kinase in the control of cardiac metabolism and remodeling. Curr. Heart Fail. Rep. 9, 164\u2013173 (2012).","journal-title":"Curr. Heart Fail. Rep."},{"key":"BFnrm3495_CR108","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/nm1137","volume":"10","author":"R Shibata","year":"2004","unstructured":"Shibata, R. et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nature Med. 10, 1384\u20131389 (2004).","journal-title":"Nature Med."},{"key":"BFnrm3495_CR109","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bbrc.2008.09.057","volume":"376","author":"E Zarrinpashneh","year":"2008","unstructured":"Zarrinpashneh, E. et al. AMPK\u03b12 counteracts the development of cardiac hypertrophy induced by isoproterenol. Biochem. Biophys. Res. Commun. 376, 677\u2013681 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrm3495_CR110","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.108.114702","volume":"52","author":"P Zhang","year":"2008","unstructured":"Zhang, P. et al. AMP activated protein kinase-\u03b12 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice. Hypertension 52, 918\u2013924 (2008).","journal-title":"Hypertension"},{"key":"BFnrm3495_CR111","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1152\/ajpendo.00443.2005","volume":"290","author":"K Sakamoto","year":"2006","unstructured":"Sakamoto, K. et al. Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPK\u03b12 but not AMPK\u03b11. Am. J. Physiol. Endocrinol. Metab. 290, e780\u2013e788 (2006).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrm3495_CR112","doi-asserted-by":"crossref","first-page":"35839","DOI":"10.1074\/jbc.M109.057273","volume":"284","author":"Y Ikeda","year":"2009","unstructured":"Ikeda, Y. et al. Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction. J. Biol. Chem. 284, 35839\u201335849 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3495_CR113","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCRESAHA.108.190918","volume":"104","author":"S Gundewar","year":"2009","unstructured":"Gundewar, S. et al. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ. Res. 104, 403\u2013411 (2009). Shows that metformin exerts its cardioprotective effects through AMPK activation.","journal-title":"Circ. Res."},{"key":"BFnrm3495_CR114","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1073\/pnas.0609202104","volume":"104","author":"A Maloyan","year":"2007","unstructured":"Maloyan, A. et al. Exercise reverses preamyloid oligomer and prolongs survival in \u03b1B-crystallin-based desmin-related cardiomyopathy. Proc. Natl Acad. Sci. USA 104, 5995\u20136000 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3495_CR115","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/01.RES.0000205766.97556.00","volume":"98","author":"JP Konhilas","year":"2006","unstructured":"Konhilas, J. P. et al. Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circ. Res. 98, 540\u2013548 (2006).","journal-title":"Circ. Res."},{"key":"BFnrm3495_CR116","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A Care","year":"2007","unstructured":"Care, A. et al. MicroRNA-133 controls cardiac hypertrophy. Nature Med. 13, 613\u2013618 (2007).","journal-title":"Nature Med."},{"key":"BFnrm3495_CR117","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/HYPERTENSIONAHA.111.185801","volume":"59","author":"T Fernandes","year":"2012","unstructured":"Fernandes, T. et al. Exercise training prevents the microvascular rarefaction in hypertension balancing angiogenic and apoptotic factors: role of microRNAs-16, -21, and -126. Hypertension 59, 513\u2013520 (2012).","journal-title":"Hypertension"},{"key":"BFnrm3495_CR118","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCRESAHA.111.248880","volume":"109","author":"ER Porrello","year":"2011","unstructured":"Porrello, E. R. et al. MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ. Res. 109, 670\u2013679 (2011).","journal-title":"Circ. Res."},{"key":"BFnrm3495_CR119","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.1139089","volume":"316","author":"E van Rooij","year":"2007","unstructured":"van Rooij, E. et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575\u2013579 (2007).","journal-title":"Science"},{"key":"BFnrm3495_CR120","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1172\/JCI36154","volume":"119","author":"TE Callis","year":"2009","unstructured":"Callis, T. E. et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 119, 2772\u20132786 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrm3495_CR121","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/MCB.00581-10","volume":"31","author":"H Nishi","year":"2011","unstructured":"Nishi, H. et al. MicroRNA-27a regulates \u03b2 cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor \u03b21 in neonatal rat ventricular myocytes. Mol. Cell. Biol. 31, 744\u2013755 (2011).","journal-title":"Mol. Cell. Biol."}],"container-title":["Nature Reviews Molecular Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrm3495.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrm3495","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrm3495.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:03:41Z","timestamp":1684454621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrm3495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,21]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["BFnrm3495"],"URL":"https:\/\/doi.org\/10.1038\/nrm3495","relation":{},"ISSN":["1471-0072","1471-0080"],"issn-type":[{"value":"1471-0072","type":"print"},{"value":"1471-0080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,21]]}}}